{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:25:02Z","timestamp":1788582302865,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s13300-019-0599-1","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T08:17:37Z","timestamp":1553156257000},"page":"929-936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Real-Life Management and Effectiveness of Insulin Pump with or Without Continuous Glucose Monitoring in Adults with Type 1 Diabetes"],"prefix":"10.1007","volume":"10","author":[{"given":"Clara","family":"Vi\u00f1als","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marga","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Conget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"599_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1464-5491.2008.02486.x","volume":"25","author":"JC Pickup","year":"2008","unstructured":"Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008;25:765\u201374.","journal-title":"Diabet Med"},{"key":"599_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/dmrr.931","volume":"25","author":"D Bruttomesso","year":"2009","unstructured":"Bruttomesso D, Costa S, Baritussio A. Continuous subcutaneous insulin infusion (CSII) 30\u00a0years later: still the best option for insulin therapy. Diabetes Metab Res Rev. 2009;25:99\u2013111.","journal-title":"Diabetes Metab Res Rev"},{"key":"599_CR3","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/dme.13094","volume":"33","author":"C Quir\u00f3s","year":"2016","unstructured":"Quir\u00f3s C, Gim\u00e9nez M, R\u00edos P, et al. Long-term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control. Diabet Med. 2016;33:1422\u20136.","journal-title":"Diabet Med"},{"key":"599_CR4","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1007\/s00125-012-2708-9","volume":"55","author":"T Battelino","year":"2012","unstructured":"Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012;55:3155\u201362.","journal-title":"Diabetologia"},{"key":"599_CR5","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJMoa0805017","volume":"359","author":"W Tamborlane","year":"2008","unstructured":"Tamborlane W, Beck R, Bode B, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1464\u201376.","journal-title":"N Engl J Med"},{"key":"599_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2016.19975","volume":"317","author":"RW Beck","year":"2017","unstructured":"Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections. JAMA. 2017;317:371.","journal-title":"JAMA"},{"key":"599_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jama.2016.19976","volume":"317","author":"M Lind","year":"2017","unstructured":"Lind M, Polonsky W, Hirsch IB, et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections. JAMA. 2017;317:379.","journal-title":"JAMA"},{"key":"599_CR8","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1177\/1932296817700161","volume":"11","author":"L Marchand","year":"2017","unstructured":"Marchand L, Kawasaki-Ogita Y, Place J, et al. Long-term effects of continuous subcutaneous insulin infusion on glucose control and microvascular complications in patients with type 1 diabetes. J Diabetes Sci Technol. 2017;11:924\u20139.","journal-title":"J Diabetes Sci Technol"},{"key":"599_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2337\/dc15-0078","volume":"38","author":"KM Miller","year":"2015","unstructured":"Miller KM, Foster NC, Beck RW, et al. Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015;38:971\u20138.","journal-title":"Diabetes Care"},{"key":"599_CR10","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.2337\/diacare.28.10.2361","volume":"28","author":"BW Bode","year":"2005","unstructured":"Bode BW, Schwartz S, Stubbs HA, Block JE. Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values. Diabetes Care. 2005;28:2361\u20136.","journal-title":"Diabetes Care"},{"key":"599_CR11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2337\/dc17-1604","volume":"41","author":"MB Abraham","year":"2018","unstructured":"Abraham MB, Nicholas JA, Smith GJ, et al. Reduction in hypoglycemia with the predictive low-glucose management system: a long-term randomized controlled trial in adolescents with type 1 diabetes. Diabetes Care. 2018;41:303\u201310.","journal-title":"Diabetes Care"},{"key":"599_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/dia.2012.0288","volume":"15","author":"K N\u00f8rgaard","year":"2013","unstructured":"N\u00f8rgaard K, Scaramuzza A, Bratina N, et al. Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. Diabetes Technol Ther. 2013;15:273\u201380.","journal-title":"Diabetes Technol Ther"},{"key":"599_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00592-016-0927-0","volume":"54","author":"AE Scaramuzza","year":"2017","unstructured":"Scaramuzza AE, Arnaldi C, Cherubini V, et al. Use of the predictive low glucose management (PLGM) algorithm in Italian adolescents with type 1 diabetes: CareLink\u2122 data download in a real-world setting. Acta Diabetol. 2017;54:317\u20139.","journal-title":"Acta Diabetol"},{"key":"599_CR14","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1089\/dia.2018.0199","volume":"20","author":"PI Beato-V\u00edbora","year":"2018","unstructured":"Beato-V\u00edbora PI, Quir\u00f3s-L\u00f3pez C, L\u00e1zaro-Mart\u00edn L, et al. Impact of sensor-augmented pump therapy with predictive low-glucose suspend function on glycemic control and patient satisfaction in adults and children with type 1 diabetes. Diabetes Technol Ther. 2018;20:738\u201343.","journal-title":"Diabetes Technol Ther"},{"key":"599_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.endinu.2018.03.009","volume":"65","author":"AM G\u00f3mez","year":"2018","unstructured":"G\u00f3mez AM, Henao DC, Imitola A, et al. Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend. Endocrinol Diabetes Nutr. 2018;65:451\u20137.","journal-title":"Endocrinol Diabetes Nutr"},{"key":"599_CR16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1089\/dia.2014.0257","volume":"17","author":"P Agrawal","year":"2015","unstructured":"Agrawal P, Zhong A, Welsh JB, Shah R, Kaufman FR. Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps. Diabetes Technol Ther. 2015;17:316\u20139.","journal-title":"Diabetes Technol Ther"},{"key":"599_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/dia.2016.0216","volume":"18","author":"A Zhong","year":"2016","unstructured":"Zhong A, Choudhary P, McMahon C, et al. Effectiveness of automated insulin management features of the MiniMed\u00ae 640G sensor-augmented insulin pump. Diabetes Technol Ther. 2016;18:657\u201363.","journal-title":"Diabetes Technol Ther"},{"key":"599_CR18","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/dme.12825","volume":"32","author":"T Battelino","year":"2015","unstructured":"Battelino T, Liabat S, Veeze HJ, Casta\u00f1eda J, Arrieta A, Cohen O. Routine use of continuous glucose monitoring in 10,501 people with diabetes mellitus. Diabet Med. 2015;32:1568\u201374.","journal-title":"Diabet Med"},{"key":"599_CR19","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.2337\/dc06-1134","volume":"29","author":"D Deiss","year":"2006","unstructured":"Deiss D, Bolinder J, Riveline J-P, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29:2730\u20132.","journal-title":"Diabetes Care"},{"key":"599_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/dia.2008.0068","volume":"10","author":"IB Hirsch","year":"2008","unstructured":"Hirsch IB, Abelseth J, Bode BW, et al. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther. 2008;10:377\u201383.","journal-title":"Diabetes Technol Ther"},{"key":"599_CR21","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s00125-009-1365-0","volume":"52","author":"MA O\u2019Connell","year":"2009","unstructured":"O\u2019Connell MA, Donath S, O\u2019Neal DN, et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia. 2009;52:1250\u20137.","journal-title":"Diabetologia"},{"issue":"3","key":"599_CR22","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1210\/jc.2017-02498","volume":"103","author":"S Charleer","year":"2018","unstructured":"Charleer S, Mathieu C, Nobels F, et al. Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study. J Clin Endocrinol Metab. 2018;103(3):1224\u201332.","journal-title":"J Clin Endocrinol Metab"},{"key":"599_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.endonu.2015.03.013","volume":"62","author":"C Quir\u00f3s","year":"2015","unstructured":"Quir\u00f3s C, Gim\u00e9nez M, Orois A, Conget I. Metabolic control after years of completing a clinical trial on sensor-augmented pump therapy. Endocrinol Nutr. 2015;62:447\u201350.","journal-title":"Endocrinol Nutr"},{"key":"599_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/dia.2016.0332","volume":"19","author":"AM G\u00f3mez","year":"2017","unstructured":"G\u00f3mez AM, Mar\u00edn Carrillo LF, Mu\u00f1oz Velandia OM, et al. Long-term efficacy and safety of sensor augmented insulin pump therapy with low-glucose suspend feature in patients with type 1 diabetes. Diabetes Technol Ther. 2017;19:109\u201314.","journal-title":"Diabetes Technol Ther"},{"key":"599_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4158\/EP14187.OR","volume":"21","author":"R Tanenberg","year":"2015","unstructured":"Tanenberg R, Welsh J. Patient behaviors associated with optimum glycemic outcomes with sensor-augmented pump therapy: insights from the Star 3 study. Endocr Pract. 2015;21:41\u20135.","journal-title":"Endocr Pract"},{"key":"599_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/dia.2014.0224","volume":"17","author":"A Deeb","year":"2015","unstructured":"Deeb A, Abu-Awad S, Abood S, et al. Important determinants of diabetes control in insulin pump therapy in patients with type 1 diabetes mellitus. Diabetes Technol Ther. 2015;17:166\u201370.","journal-title":"Diabetes Technol Ther"},{"key":"599_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.endonu.2014.01.003","volume":"61","author":"C Quir\u00f3s","year":"2014","unstructured":"Quir\u00f3s C, Patrascioiu I, Gim\u00e9nez M, et al. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes. Endocrinol Nutr. 2014;61:318\u201322.","journal-title":"Endocrinol Nutr"},{"key":"599_CR28","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.numecd.2012.04.001","volume":"22","author":"G Lepore","year":"2012","unstructured":"Lepore G, Dodesini AR, Nosari I, et al. Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with type 1 diabetes. Nutr Metab Cardiovasc Dis. Elsevier B.V. 2012;22:e15\u20136.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"599_CR29","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2337\/dc16-2482","volume":"40","author":"G Aleppo","year":"2017","unstructured":"Aleppo G, Ruedy KJ, Riddlesworth TD, et al. REPLACE-BG: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. Diabetes Care. 2017;40:538\u201345.","journal-title":"Diabetes Care"},{"key":"599_CR30","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc17-1600","volume":"40","author":"T Danne","year":"2017","unstructured":"Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40:1631\u201340.","journal-title":"Diabetes Care"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-019-0599-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-019-0599-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-019-0599-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:33:22Z","timestamp":1724412802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-019-0599-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1007\/s13300-019-0599-1","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]},"assertion":[{"value":"29 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}